A monoacylglycerol lipase inhibitor showing therapeutic efficacy in mice without central side effects or dependence
- Author(s):
- Jiang, M.; Huizenga, M.C.W.; Wirt, J.L.; Paloczi, J.; Amedi, A.; Berg, R.J.B.H.N. van den (0000-0002-8585-3904); Benz, J.; Collin, L.; Deng, H.; Di, X.; Driever, W.P.F. (0000-0002-9250-0381); Florea, B.I. (0000-0001-7114-2266); Grether, U.; Janssen, A.P.A. (0000-0003-4203-261X); Hankemeier, T. (0000-0001-7871-2073); Heitman, L.H. (0000-0002-1381-8464); Lam, T.-W.; Mohr, F.D. (0000-0002-3613-3273); Pavlovic, A.; Ruf, I.; Hurk, H. van den; Stevens, A.F. (0000-0002-6688-4377); Vliet, D. van der (0000-0001-7317-9679); Wel, T. van der (0000-0002-6449-3233); Wittwer, M.B., Boeckel, C.A.A. van; Pacher, P.; Hohmann, A.G.; Stelt, M. van der (0000-0002-1029-5717)
- Published
- 2023
- Publication type
- Article / Letter to editor
- Date issued
- 2023-11-28
- Language
- English
- Is part of
- Nature Communications (2023), No. 1, 8039
- hdl
- 1887/4246110
- doi
- 10.1038/s41467-023-43606-3
